Vikrant verma | Biology and Life Sciences | Research Excellence Award

Published on by Soil Scientist

Research Excellence Award

Vikrant Verma
Affiliation Swami Vivekanand Subharti University
Country India
Scopus ID 57213651680
Documents 20
Citations 70
h-index 4
Subject Area Biology and Life Sciences
Event International Soil Scientist Awards
ORCID 0000-0002-1994-9641

Vikrant Verma
Swami Vivekanand Subharti University,India

Vikrant Verma of Swami Vivekanand Subharti University is presented in connection with the Research Excellence Award at the International Soil Scientist Awards. His reported scholarly record comprises 20 documents, 70 citations, and an h-index of 4, with research classified within Biology and Life Sciences. The publication record supplied for this profile reflects interdisciplinary work spanning pharmacology, natural bioactive compounds, radiopharmaceuticals, neurobiology, and cardiovascular research.

Abstract

This academic recognition profile summarizes Vikrant Verma’s documented research activity and selected recent publications. The supplied works address mechanisms of bioactive compounds, Alzheimer’s disease, alkaloid pharmacology, targeted radiopharmaceuticals, gut-brain interactions, and endothelial dysfunction. Together, these publications indicate a research portfolio connecting molecular mechanisms with therapeutic and translational questions. The bibliometric information supplied for the profile records 20 documents, 70 citations, and an h-index of 4.

Keywords

Vikrant Verma; Research Excellence Award; Biology and Life Sciences; pharmacology; bioactive compounds; Alzheimer’s disease; molecular targets; radiopharmaceuticals; gut-brain axis; cardiovascular research.

Introduction

The supplied publication record demonstrates an interdisciplinary orientation within biomedical and life-science research. Recent work includes mechanistic reviews of traditional Chinese medicine-derived compounds and Mitragyna speciosa alkaloids, as well as research concerning PSMA-targeted radiopharmaceuticals and quercetin-mediated gut-brain interactions. These subjects involve molecular pharmacology, therapeutic development, safety considerations, and translational science.

Research Profile

The reported Scopus profile identifies 20 documents, 70 citations, and an h-index of 4. These metrics provide a quantitative snapshot of indexed scholarly output and citation activity and should be interpreted in relation to field, publication age, document type, and database coverage. [1]

Research Contributions

  • Analysis of molecular targets, standardization, and translational considerations for TCM-derived bioactive compounds in Alzheimer’s disease.
  • Examination of structure-activity relationships and safety profiles associated with Mitragyna speciosa alkaloids.
  • Review of PSMA-targeted radiopharmaceutical design and clinical translation.
  • Investigation of quercetin, microbiome modulation, and neuroprotective mechanisms involving the gut-brain axis.
  • Assessment of therapeutic strategies addressing endothelial dysfunction across cardiovascular and systemic diseases.

Publications

Selected publications supplied for this profile include the 2026 article on TCM-derived bioactive compounds in Pharmacological Research – Modern Chinese Medicine, the study of Mitragyna speciosa alkaloids in Current Bioactive Compounds, and work on PSMA-targeted radiopharmaceuticals in Current Radiopharmaceuticals. Additional publications address quercetin and the gut-brain axis and therapeutic strategies for endothelial dysfunction. [2] [3] [4]

Research Impact

The reported citation count and h-index document measurable scholarly visibility in indexed literature. The subject diversity of the selected publications also illustrates engagement with several areas of biomedical research, including neurodegeneration, natural-product pharmacology, molecular imaging, and vascular biology. Citation metrics are dynamic and may change as databases are updated. [1]

Award Suitability

The supplied record provides several documented elements relevant to an academic recognition profile: indexed publications, citation activity, an h-index, and recent research addressing contemporary questions in Biology and Life Sciences. The combination of mechanistic pharmacology, therapeutic investigation, and translational biomedical themes provides a substantive basis for consideration under a research-excellence framework, subject to the award’s formal evaluation criteria and verification procedures.

Conclusion

Vikrant Verma’s supplied academic profile reflects research activity in Biology and Life Sciences with publications covering molecular pharmacology and several translational biomedical themes. The reported Scopus metrics and selected 2026 publications provide measurable and recent indicators of scholarly activity. Continued publication, citation development, and interdisciplinary research may further document the evolution of this research profile.

References

  1. Elsevier. (n.d.). Scopus author details: Vikrant Verma, Author ID 57213651680. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57213651680
  2. Verma, V. (2026). Mechanistic pharmacology of TCM-derived bioactive compounds in Alzheimer’s disease: molecular targets, standardization, and translational insights. Pharmacological Research – Modern Chinese Medicine. DOI: 10.1016/j.prmcm.2026.100831
  3. Verma, V. (2026). Mechanistic Insights, Structure-activity Relationships, and Safety Profile of Mitragyna speciosa Alkaloids. Current Bioactive Compounds. DOI: 10.2174/0115734072492003260811045218
  4. Verma, V. (2026). Theranostic applications of PSMA-targeted radiopharmaceuticals: From molecular design to clinical translation and emerging paradigms. Current Radiopharmaceuticals. DOI: 10.1016/j.craph.2026.100054
  5. Verma, V. (2026). Quercetin and the gut-brain axis: Microbiome modulation, neuroprotection, and therapeutic implications. AIMS Molecular Science. DOI: 10.3934/molsci.2026012
  6. Verma, V. (2026). Therapeutic Strategies for Endothelial Dysfunction in Cardiovascular Disease, Rheumatoid Arthritis, and Diabetes: Current and Emerging Approaches. Cardiovascular & Hematological Agents in Medicinal Chemistry. DOI: 10.2174/0118715257414596251206101856

Ritu Dahiya | Biology | Women Researcher Award

Published on by Soil Scientist

Mrs. Ritu Dahiya | Biology | Women Researcher Award

Lingaya’s vidyapeeth | India 

Mrs. Ritu Dahiya is a dedicated academic and researcher whose work spans diabetes-related complications, ocular drug discovery, biomarker identification, and the pharmacology of infectious diseases. With a growing research footprint reflected through an h-index of 2, eight documents, and eight citations, she contributes meaningfully to advancing pharmacological science and healthcare innovation. Her professional journey includes expertise in understanding the mechanisms of retinopathy, cardiomyopathy, and nephropathy, along with a strong orientation toward translational ocular therapeutics. She has actively supported scientific communities as a resource person, evaluator, and judge across diverse academic platforms, demonstrating her commitment to research dissemination and academic leadership. Alongside her research achievements, she has cultivated strong organizational capabilities by coordinating academic conferences, establishing collaborations, initiating skill-development programs, and facilitating industry-academia interactions. Her experience extends to curriculum enhancement, program coordination, and student development through seminars, webinars, and certificate courses. Additionally, she has contributed to teaching pharmacology and science education at multiple levels, enriching learners’ conceptual understanding and practical insights. Overall, her profile reflects a balanced blend of research excellence, academic service, and pedagogical commitment within the pharmaceutical and life sciences domain.

Profile : Scopus

Featured Publications

Mathur, P., Goyal, K., Singh, A. P., Gauba, A., & Dahiya, R. (2025). Omics-driven insights and microarray applications in drug discovery and development. Medicine, Biology, Computational Biology and Chemistry.

Tarnjot Kaur | Biology | Best Researcher Award

Published on by Soil Scientist

Ms. Tarnjot Kaur | Biology | Best Researcher Award

Tarnjot Kaur | University of Petroleum and Energy Studies | India

Tarnjot Kaur is a Research Scholar at UPES, Dehradun, with a strong academic foundation in pharmacy, having completed both her bachelor’s and master’s degrees in the field. She has built her expertise in the area of pharmaceutical sciences, particularly focusing on nanomedicine and topical drug delivery systems. Her professional journey reflects a blend of academic rigor and innovative research experience, with active involvement in formulation design, drug characterization, and preclinical evaluation of novel therapeutic systems. She has gained valuable exposure through collaborations with reputed institutions such as Dr. Vishwanath Karad MIT World Peace University, Lupin Research Park, and Prince Sattam Bin Abdulaziz University, which has enriched her experience in interdisciplinary research. Her technical skills lie in pharmaceutical formulation development, nanotechnology-based drug delivery, and advanced topical therapy strategies aimed at enhancing skin penetration, drug stability, and patient compliance. In recognition of her scholarly contributions, she has published multiple review articles and a research paper in indexed journals, alongside filing two patents currently under process, which highlights her commitment to innovation and translational research. Her research focus is centered on improving the management of skin diseases like psoriasis by designing safer, more effective, and patient-friendly treatments using polymeric nanoparticle-based delivery systems. With her innovative work in pharmaceutical sciences and her potential as an emerging scientist, she exemplifies dedication to advancing dermatological therapeutics through nanotechnology-driven approaches.

Profile:  ORCID

Featured Publications

1. Title: Emerging Therapeutic Agents and Nanotechnology-Driven Innovations in Psoriasis Management
Authors: Tarnjot Kaur, Nikita Hinge, Sudeep Pukale, Mohd Nazam Ansari, Kamal Y. Thajudeen, Mukesh Nandave, Jyoti Upadhyay
Journal: Frontiers in Bioscience – Landmark

2. Title: Exploring Progress in Iron Supplement Formulation Approaches for Treating Iron Deficiency Anemia Through Bibliometric and Thematic Analysis
Authors: Tarnjot Kaur, Jyoti Upadhyay, Mukesh Nandave, Abdulrhman Alsayari, Saad Ali Alshehri, Sudeep Pukale, Shadma Wahab, Wasim Ahmad, Summya Rashid, Mohd Nazam Ansari
Journal: Heliyon

Aminur Rahman | Biological Sciences | Best Researcher Award

Published on by Soil Scientist

Assoc. Prof. Dr. Aminur Rahman | Biological Sciences | Best Researcher Award

Assoc. Prof. Dr. Aminur Rahman, King Faisal University, Saudi Arabia

Assoc. Prof. Dr. Aminur Rahman is a faculty member in the Department of Biomedical Sciences at the College of Clinical Pharmacy, King Faisal University, Saudi Arabia. With a Ph.D. in Biology from Örebro University, Sweden, his research focuses on biochemistry, microbiology, and environmental biotechnology, particularly bioremediation of toxic metals and wastewater treatment. He has held prestigious postdoctoral positions in Sweden and Japan and has received several international awards for his contributions to environmental science.

Profile

Scopus

Summary:

Assoc. Prof. Dr. Aminur Rahman is an accomplished academic and researcher whose body of work spans critical areas of biotechnology, microbiology, and environmental health. With significant international exposure, diverse high-impact publications, and recognized scientific contributions, he stands out as a valuable asset to the research community in Saudi Arabia and beyond.

🎓 Education

Dr. Aminur Rahman holds a Ph.D. in Biology from Örebro University, Sweden, where his research focused on the bioremediation of toxic metals to safeguard human health and ecosystems. He earned dual Master of Science degrees in Biomedicine and Molecular Biology from the University of Skövde, Sweden, concentrating on microbial bioremediation and gene characterization. His academic foundation began with a Bachelor of Science in Biochemistry and Molecular Biology from the University of Rajshahi, Bangladesh, where he was recognized with a gold medal for outstanding academic performance.

💼Experience

Dr. Rahman is currently serving as an Assistant Professor in the Department of Biomedical Sciences, College of Clinical Pharmacy at King Faisal University, Saudi Arabia, where he teaches biochemistry, metabolism, and food and nutrition. Prior to this, he was a JSPS Postdoctoral Researcher at Saga University, Japan, working on developing natural composite membranes for heavy metal removal. He also served as a Postdoctoral Researcher at Örebro University, Sweden, where he investigated antibiotic resistance in aquatic environments. Earlier in his career, he worked as a Lecturer at the University of Skövde, delivering advanced-level lectures in biochemistry, microbiology, and molecular biology.

🔬Research Focus

His research spans biotechnology, microbiology, and environmental science, with a particular focus on bioremediation, wastewater treatment, and the creation of novel bio-based materials for the adsorption and removal of environmental contaminants. He is especially interested in interdisciplinary approaches that address healthcare, agriculture, pharmaceutical innovation, and sustainable environmental solutions aligned with Saudi Arabia’s scientific priorities.

🛠️Skills

Dr. Rahman is proficient in advanced molecular biology techniques, genetic engineering, microbial bioremediation, and bioinformatics. He has hands-on expertise in MALDI-ToF mass spectrometry, environmental sampling, and microbiological assays. He is also skilled in higher education pedagogy, curriculum development, interdisciplinary collaboration, and scientific communication through lectures, publications, and presentations at international forums.

🏆Awards

Dr. Rahman has received numerous accolades, including the prestigious JSPS Postdoctoral Fellowship in Japan (2020), and awards for poster presentations at international conferences held in the USA, Portugal, and Spain. He was also a recipient of the Nilsson-Ehle Foundation grant by the Royal Physiographic Society of Sweden and earned a gold medal from the University of Rajshahi for academic excellence.

📚 Publications

  • Title: Dynamics of Antimicrobial Susceptibility and Risk Factors Associated with Infections Caused by Colistin‑Resistant Bacteria: A Study from the Northern Region of Haryana, India
    Year: 2025
    Journal: Polish Journal of Microbiology

  • Title: Radiometric Hazard Assessment of Soil and Water Samples Adjacent to Bangladesh’s First Nuclear Power Plant Before Commissioning: Insights into Human Health and Environmental Radiological Dynamics
    Year: 2024
    Journal: Heliyon

  • Title: Promising and Environmentally Friendly Removal of Copper, Zinc, Cadmium, and Lead from Wastewater Using Modified Shrimp-Based Chitosan
    Year: 2024
    Journal: Water (Switzerland)

  • Title: Baseline Radioactivity in the Five Candidate Sites for the Second Nuclear Power Plant in Bangladesh and Concomitant Hazards Assessment
    Year: 2024
    Journal: International Journal of Environmental Analytical Chemistry

  • Title: Characterization of Lignin and Hemicellulose Degrading Bacteria Isolated from Cow Rumen and Forest Soil: Unveiling a Novel Enzymatic Model for Rice Straw Deconstruction
    Year: 2023
    Journal: Science of the Total Environment

Conclusion:

Dr. Aminur Rahman is a strong candidate for the Best Researcher Award. His consistent publication output, interdisciplinary focus, international collaborations, and alignment with sustainable and healthcare research goals make him deserving of recognition. With continued leadership in research grants, mentoring, and translational science, his profile will further strengthen in coming years.